1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends
  5. > Mental Health Analysis & Statistics in Italy, May 2019

Mental Health Analysis & Statistics in Italy, May 2019

Customer Support

Talk to Veronica

+1 718 514 2762

All regions

1-30 of 94 reports

Zambon Company SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Zambon Company SpA - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • November 2018

SummaryZambon Company SpA (Zambon) is a manufacturer of pharmaceutical and fine chemical products.It offers pharmaceutical products for respiratory, central nervous system, pain management, women’s healthcare ...

  • Industries : Pharmaceutical
  • Countries : United States, Italy
Italy Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

Italy Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and Others

  • $ 5995
  • Industry report
  • November 2018

Italy Neurology Devices Market Outlook to 2025 - Hydrocephalus Shunts, Interventional Neuroradiology Devices, Neurosurgical Products and OthersSummaryGlobalData’s new report, Italy Neurology Devices ...

  • Industries : Health Services, Healthcare, Patient Monitoring, Medical Device, Mental Health, Pathology
  • Countries : Italy, Southern Europe
Drug Overview: Latuda

Drug Overview: Latuda

  • $ 10000
  • Industry report
  • April 2018

Drug Overview Latuda (lurasidone; Sumitomo Dainippon/Angelini) contains the atypical antipsychotic lurasidone, which acts as an antagonist of dopamine receptors D2, and serotonin receptors 5-HT2A. By ...

  • Industries : Mental Health, Pathology
  • Countries : United Kingdom, Italy, Japan, European Union, United States, Germany, Spain
EPIOMIC EPIDEMIOLOGY SERIES: EPILEPSY FORECAST IN 19 MAJOR MARKETS 2018–2028

EPIOMIC EPIDEMIOLOGY SERIES: EPILEPSY FORECAST IN 19 MAJOR MARKETS 2018–2028

  • $ 5577
  • Industry report
  • April 2018

Black Swan Analysis Epiomic™ Epidemiology Forecast Report on Epilepsy in 19 Major MarketsEpilepsy is a complex neurologic disorder characterised by the occurrence of seizures, divided into several types ...

  • Industries : Mental Health, Pathology
  • Countries : Italy, Spain, Poland, Germany, France
EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026

  • $ 3995
  • Industry report
  • October 2017

EpiCast Report: Alzheimer’s Disease - Epidemiology Forecast to 2026SummaryAlzheimer’s disease (AD) is a subtype of dementia and is an irreversible, neurodegenerative brain disease of the elderly, characterized ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World, Spain, Japan, Italy, Germany, France, United Kingdom
Datamonitor Healthcare Parkinson’s Disease KOL Interviews

Datamonitor Healthcare Parkinson’s Disease KOL Interviews

  • $ 599
  • Industry report
  • April 2017

March 16, 2017Datamonitor Healthcare interviewed two neurologists, one based in Italy and the other in the US, to gauge their prescribing habits and views on current treatment options and challenges, late-stage ...

  • Industries : Mental Health, Pathology
  • Countries : Italy, United States
Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Huntington’s Disease patients study in a new report ‘Global Huntington’s Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Disorder patients study in a new report ‘Europe Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Bipola ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

Europe Gaucher%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Gaucher's Disease patients study in a new report ‘Europe Gaucher's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2017

Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Attention Deficit Hyperactivity Disorder patients study in a new report ‘Global Attention Deficit Hyperactivity Disorder Epidemiology and Patient Flow Analysis ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Depression patients study in a new report ‘Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

Europe Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Europe Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Unipolar Depression patients study in a new report ‘Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Epilepsy Epidemiology and Patient Flow Analysis - 2017

Global Epilepsy Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Global Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Epilepsy patients study in a new report ‘Europe Epilepsy Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Epilepsy epidemiology, ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Europe Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017

Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Obsessive Compulsive Disorder patients study in a new report ‘Europe Obsessive Compulsive Disorder Epidemiology and Patient Flow Analysis - 2017’. The report ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017

Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Anxiety Disorder patients study in a new report ‘Global Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Anxiety ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Multiple Sclerosis patients study in a new report ‘Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Schizophrenia Epidemiology and Patient Flow Analysis - 2017

Global Schizophrenia Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Schizophrenia patients study in a new report ‘Global Schizophrenia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Schizophrenia ...

  • Industries : Mental Health, Pathology
  • Countries : United States, World, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Major Depression Epidemiology and Patient Flow Analysis - 2017

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Major Depression patients study in a new report ‘Europe Major Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Majo ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Addiction Disorder Epidemiology and Patient Flow Analysis - 2017

Europe Addiction Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Addiction Disorder patients study in a new report ‘Europe Addiction Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Depression patients study in a new report ‘Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Panic Disorder Epidemiology and Patient Flow Analysis - 2017

Global Panic Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Panic Disorder patients study in a new report ‘Global Panic Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Panic ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017

Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Schizophrenia patients study in a new report ‘Europe Schizophrenia Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Schizophrenia ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom
Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Bipolar Disorder patients study in a new report ‘Global Bipolar Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Bipola ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

Global Parkinson%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Parkinson's Disease patients study in a new report ‘Global Parkinson's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Global Alzheimer%s Disease Epidemiology and Patient Flow Analysis - 2017

Global Alzheimer%s Disease Epidemiology and Patient Flow Analysis - 2017

  • $ 1790
  • Industry report
  • January 2017

Fore Pharma announced the results of its Alzheimer's Disease patients study in a new report ‘Global Alzheimer's Disease Epidemiology and Patient Flow Analysis - 2017’. The report provides insights ...

  • Industries : Mental Health, Pathology
  • Countries : World, United States, Germany, France, Spain, Italy, United Kingdom, Japan
Europe Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017

Europe Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017

  • $ 1390
  • Industry report
  • January 2017

Fore Pharma announced the results of its Anxiety Disorder patients study in a new report ‘Europe Anxiety Disorder Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Anxiety ...

  • Industries : Mental Health, Pathology
  • Countries : Europe, Germany, France, Spain, Italy, United Kingdom

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on